Men’s Health

New blood test may someday help guide the best treatment for aggressive prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Research in a small group of men with advanced prostate cancer found that a blood test that screens for a certain genetic mutation could help decide which of two types of drugs would be more likely to provide a longer lifespan.

New study once again casts doubt on PSA screening

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

The largest study to date of prostate cancer screening reinforces the existing evidence that the potential benefits of the test are outweighed by the harms of overtreatment for low-grade cancer that could be left untreated.

A mix of treatments may extend life for men with aggressive prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Combining multiple forms of radiation therapy with hormone treatments lengthens survival in men with aggressive prostate cancer.

FDA approves new drug for men at high risk of prostate cancer spread

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men whose PSA levels continue rising even after surgery or radiation therapy may have a new treatment option with the approval of the drug apalutamide.

Newer drugs are improving survival for men with metastatic prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men with prostate cancer that has spread outside the gland now have several newer drug options available for treatment, and research has found that taking any of them is likely to improve survival duration.

Is “man flu” really a thing?

Robert H. Shmerling, MD

Faculty Editor, Harvard Health Publishing

The concept of “man flu” sounds like a joke or a ploy for sympathy, but men and women do experience other diseases and conditions differently, and there is some evidence that this is also true of the influenza virus.

We heard you — incontinence affects men too. Here’s what you need to know

Matthew Solan

Executive Editor, Harvard Men's Health Watch

Urinary incontinence is more common in women, but men experience it too, particularly as they get older. Whether it’s urge incontinence or stress incontinence, there are strategies and treatments that can help.

Study investigates treatment regret among prostate cancer survivors

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Surveys of over 900 men who were diagnosed with prostate cancer in the 1990s found that approximately 15% had some regret over their treatment choices. Study authors encourage doctors and patients to have frank and thorough discussions about about the risks and benefits of various forms of treatment for prostate cancer.

Time to rethink the debate on PSA testing

The debate about PSA screening for prostate cancer has been going on for decades, and research has been similarly divided. For most men, the best advice is to talk with your doctor so the benefits and risks of the test are clear.

Men (back) at work

Matthew Solan

Executive Editor, Harvard Men's Health Watch

Because men bond through shared experiences such as work, recreating the dynamics of the workplace can help older men stay mentally sharp and socially active.